|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 14/34 | (2006.01) |
| C07K2319/034 | (2013.01) | ||
| C12N 15/62 | (2006.01) | ||
| C07K 14/34 | (2013.01) | ||
| C12N 9/1077 | (2013.01) | ||
| C12Y 204/02036 | (2013.01) | ||
| A61P 31/04 | (2018.01) |
| (11) | Number of the document | 3480209 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18167370.8 |
| Date of filing the European patent application | 2010-10-07 | |
| (97) | Date of publication of the European application | 2019-05-08 |
| (45) | Date of publication and mention of the grant of the patent | 2023-11-29 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 0917647 | 2009-10-08 | GB |
| (72) |
BLAIS, Normand , CA
DEHOTTAY, Philippe Marc Helene , BE
DEWERCHIN, Marianne , BE
GOFFIN, Philippe , BE
MARTIN, Denis , CA
|
| (73) |
GlaxoSmithKline Biologicals S.A. ,
Rue de l'Institut, 89, 1330 Rixensart,
BE
|
| (54) | EXPRESSION SYSTEM |
| EXPRESSION SYSTEM |